The advertisement promotes Nucala (mepolizumab), highlighting that 95% of commercial patients are covered nationally and providing a call to action for accessing further details.
Creative Information
| CID: | dd3d9818-ff29-4f07-b58d-7bec95b421cf |
| CRID: | 82_2108-910575 |
| Domain: | nucalahcp.com |
| Seat: | PP |
| Size: | 300x250 |
| Bid: | $31.35 |
| Timestamp: | 11/7/2025, 2:43:53 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/7/2025, 5:14:38 PM | 5.38s | |
| adomain_analysis | success | 11/7/2025, 6:49:32 PM | 3.66s | |
| adomain_capture | success | 11/7/2025, 6:49:28 PM | 0.43s | |
| ad_render | success | 11/7/2025, 5:14:33 PM | 24.92s | |
| brand_mapping | success | 11/7/2025, 2:43:53 PM | 0.09s | |
Analysis Results
Ad Format: banner
Brands: NUCALA
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x250 | ||||||||||||||||||||||
| Data Transferred: | 1732.11 KB | ||||||||||||||||||||||
| Render Time: | 9.42 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1753.27 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

